Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Dunelm non-exec invests £0.3m, Taseko director makes £0.4m sale

(Sharecast News) - Dunelm was at the top of the list of buys on Wednesday afternoon, after it disclosed a non-executive director purchase worth almost £0.3m.

The FTSE 250 homewares and furnishings retailer said Andrew Harrison bought 28,214 shares in the company on Tuesday, at a piece of 1,055.38p each.

That valued the transaction at a total of £297,764.90.

Following the new investment, Dunelm said Harrison's total beneficial holding now stood at 444,694 of its shares, or 0.22% of its issued capital.

On the selling side of things, Taseko Mines reported that one of its directors had disposed of more than CAD 0.7m (£0.43m) of shares.

The London-listed firm said Russell Hallbauer sold 407,000 shares on the Toronto Stock Exchange over the week up to Tuesday, at a price of 286 Canadian cents apiece.

That netted him a total of CAD 688,647.37.

Top Director Buys

Dunelm Group (DNLM) Director name: Harrison ,Andy Amount purchased: 28,214 @ 1,055.38p Value: £297,764.90

Witan Inv Trust (WTAN) Director name: Ross ,Andrew Amount purchased: 50,000 @ 225.00p Value: £112,500.00

Jtc (JTC) Director name: Holley,Wendy Amount purchased: 13,088 @ 760.20p Value: £99,494.98

Thruvision Group (THRU) Director name: Nurse,Katrina Amount purchased: 67,000 @ 29.90p Value: £20,033.00

Thruvision Group (THRU) Director name: Nurse,Katrina Amount purchased: 67,000 @ 29.90p Value: £20,033.00

The Mission Group (TMG) Director name: Clifton,James Amount purchased: 23,739 @ 65.40p Value: £15,525.31

Mortgage Advice Bureau (holdings) (MAB1) Director name: Tilley,Lucy Amount purchased: 22 @ 1,330.00p Value: £292.60

Mortgage Advice Bureau (holdings) (MAB1) Director name: Thompson,Ben Amount purchased: 22 @ 1,330.00p Value: £292.60

Victrex Plc (VCT) Director name: Court ,Martin Amount purchased: 8 @ 1,754.00p Value: £140.32

Top Director Sells

Tremor International Ltd (di) (TRMR) Director name: Carmi ,Yaniv Amount sold: 245,270 @ $7.42 Value: $1,500,703.73

Taseko Mines Limited Npv (di) (TKO) Director name: Hallbauer,Russell Amount sold: 407,000 @ $2.86 Value: $688,647.37

Tremor International Ltd (di) (TRMR) Director name: Druker,Ofer Amount sold: 39,800 @ $6.52 Value: $213,982.02

Tremor International Ltd (di) (TRMR) Director name: Druker,Ofer Amount sold: 35,200 @ $6.70 Value: $194,475.13

Tremor International Ltd (di) (TRMR) Director name: Druker,Ofer Amount sold: 25,400 @ $6.59 Value: $138,027.55

Tremor International Ltd (di) (TRMR) Director name: Druker,Ofer Amount sold: 23,884 @ $6.73 Value: $132,546.65

Tremor International Ltd (di) (TRMR) Director name: Druker,Ofer Amount sold: 20,400 @ $6.34 Value: $106,651.28

Tremor International Ltd (di) (TRMR) Director name: Druker,Ofer Amount sold: 15,400 @ $6.55 Value: $83,178.03

Deliveroo Class A (ROO) Director name: Miller,Adam Amount sold: 40,396 @ 105.97p Value: £42,807.64

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.